Not finding it? Sign in to also search OpenAlex live.
-
JS01.3.A FULLY AUTOMATED EVALUATION OF FET PET IN BRAIN TUMOR PATIENTS - AN INTERNATIONAL, MULTICENTER STUDY2025 Neuro-Oncology conference-abstract Medicine Medical Imaging Techniques and Applications Open access
Keith George Ciantar, Shaun D Grega, Nathaniel J. Smith, Matt Larson, Mark A. Tann, Wendy L. Territo, +15 more
0citations -
Abstract PD6-11: PD6-11 Evaluation of the Sensitivity to Endocrine Therapy Index (SET2,3) in Early Male Breast Cancer: Results from an analysis in the EORTC 10085/TBCRC/BIG/NCTN International Male Breast Cancer Program
Danielle Brandes Zakon, Coralie Poncet, Fátima Cardoso, Neven Anouk, Vicente Valero, Stefan Paul Aebi, +28 more
0citations -
Abstract GS5-10: Utility of the 70-gene MammaPrint test for prediction of extended endocrine therapy benefit in patients with early-stage breast cancer in the IDEAL Trial2023 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Gerrit‐Jan Liefers, Elma Meershoek‐Klein Kranenbarg, Marjolijn Duijm‐de Carpentier, Cornelis J.�H. van de Velde, Miranda Kleijn, Christa Dreezen, +3 more
9citations -
JS04.6.A CLINICAL PRESENTATION OF “MOLECULAR GLIOBLASTOMA” IS DIFFERENT COMPARED TO “HISTOLOGICAL GLIOBLASTOMA”, BUT OUTCOME IS THE SAME, REGARDLESS OF GRADE OR PRESENCE OF ONLY ATERT PROMOTER MUTATION
Maarten M.J. Wijnenga, Sybren L. N. Maas, Vera van Dis, C. Mircea S. Tesileanu, Johan M. Kros, Linda Dirven, +5 more
0citations -
Encouraging Outcome of AML with t(8;16) Following Allogeneic Stem Cell Transplantation in First Remission - a Retrospective Analysis on Behalf of the Acute Leukemia Working Party of the EBMT
Ann‐Kristin Schmälter, Myriam Labopin, Jurjen Versluis, Maria Pilar Gallego Hernanz, Matthias Eder, Peter A. von dem Borne, +12 more
1citations -
Abstract PD2-11: Breast cancer index is a molecular signature of endocrine responsiveness that determines extended endocrine benefit independent of prognostic risk2021 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Gerrit‐Jan Liefers, Iris Noordhoek, Kai Treuner, Hein Putter, Yi Zhang, Jenna Wong, +4 more
0citations -
SURG-83. Inter-rater agreement from an international expert panel on resectability of recurrent glioblastoma: a complementary post-hoc analysis of the prospective, randomized DIRECTOR trial
Philipp Karschnia, Nico Teske, Émilie Le Rhun, Hans‐Georg Wirsching, Asgeir Store Jakola, Constantin Roder, +12 more
0citations -
STAR-TREC phase II: Can we save the rectum by watchful waiting or transanal surgery following (chemo)radiotherapy versus total mesorectal excision for early rectal cancer?2022 Journal of Clinical Oncology conference-abstract Medicine Colorectal Cancer Surgical Treatments
Simon Parkinson Bach, Johannes H.W. de Wilt, Femke P. Peters, Karen‐Lise Garm Spindler, Ane Lindegaard Appelt, Mark T.W. Teo, +14 more
19citations -
Transformed FL shows improved survival after CAR T-cell therapy compared to de novo LBCL, but early transformation (<12 months) defines a poor-risk subgroup: Results from a nationwide cohort
Hilde T. van der Galiën, Pim G. N. J. Mutsaers, Margot Jak, Marjolein van der Poel, Marije T. Nijk, Kees Meijer, +13 more
1citations -
Cohort study of oligorecurrent prostate cancer patients: Oncological outcomes of patients treated with salvage lymph node dissection via PSMA radioguided surgery.2022 Journal of Clinical Oncology conference-abstract Medicine Prostate Cancer Diagnosis and Treatment
Tobias Maurer, Mehrdad Mehdi Irai, Isabel Rauscher, Ricarda Simon, Matthias J. Eiber, Fijs W. B. van Leeuwen, +8 more
0citations